Two-tier Lyme testing begins with a crucial distinction: a positive Lyme screening test is not, by itself, a positive Lyme test. That distinction matters when syphilis is in the differential, because antibodies produced against Treponema pallidum can react with antigens used in some Lyme disease screening assays. Treating the screen as a diagnosis can lead a clinician to label a patient with syphilis as having Lyme disease.
Lyme Disease
Lyme Disease Articles
CEHF’s “Morgellons Arthritis” Article Does Not Say What Its Sources Say
A closer reading of CEHF’s citations reveals a four-day mouse experiment described as months of joint swelling, an animal study blurred into a human PTLDS diagnosis, and a 6 percent figure whose denominator changes as it moves through the Morgellons literature.
On August 13, 2026, the Charles E. Holman Morgellons Disease Foundation published an official statement warning Morgellons patients about unnamed critics whom it accused of failing to engage properly with peer-reviewed literature and of “nitpicking” researchers. The Foundation urged patients to rely on credible sources and peer-reviewed information while presenting its own work as rooted in scientific integrity.
That is a reasonable standard, and it should apply equally to CEHF. A standing article on the Foundation’s website, Understanding Morgellons Arthritis (archived May 18, 2026), provides an unusually useful test because its claims are specific and its scientific citations can be traced back to the original studies. The article, bylined to Mark Wilcox, was published in December 2022 and last modified February 20, 2023.
The Closed Loop: When Lyme Advocacy Stops Questioning Itself
The Lyme disease community was built, in large part, by people willing to question authority. That history makes the possibility of a Lyme disease echo chamber particularly uncomfortable to discuss. Patients challenged physicians who dismissed symptoms that did not fit established diagnostic categories. Advocates questioned testing standards they believed were inadequate, while researchers pushed against assumptions about diagnosis, treatment, persistence, and coinfections. That willingness to challenge prevailing ideas has often been one of the community’s greatest strengths. It forced difficult conversations and created space for patients who felt abandoned by conventional medicine.
But skepticism only has value when we apply it consistently. A community that demands scrutiny of government agencies, professional societies, insurance companies, and academic medicine should also scrutinize its own physicians, researchers, laboratories, advocacy organizations, websites, podcasts, and influential personalities. We cannot insist that outside institutions tolerate uncomfortable questions while treating the same questions differently when they point inward. Skepticism stops functioning as a method when it depends on who receives it.
LymeX Healthathon Asks Patients What Worked—and What We Can Actually Learn From It
For years, patients with Lyme disease and other complex tick-borne illness histories have argued that some of the most important parts of their medical journeys never make it into a laboratory report. The months spent searching for an explanation can disappear into a sequence of office visits. A symptom pattern that becomes recognizable only in retrospect may be scattered across notes written by several specialists. A treatment that coincided with an unexpected change may be preserved simply as a medication start and stop date, without any meaningful account of what the patient experienced in between.
Morgellons and Lyme Disease: Evidence, Misinformation, and Support Group Red Flags
Morgellons and Lyme disease are often discussed together because many patients report overlapping symptoms, tick exposure, skin lesions, fibers, fatigue, and years of medical dismissal. Many Morgellons patients eventually find their way into Lyme disease communities, where they may finally meet people who take their suffering seriously. That support can be valuable. But it can …